0001209191-23-027361.txt : 20230504
0001209191-23-027361.hdr.sgml : 20230504
20230504163807
ACCESSION NUMBER: 0001209191-23-027361
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230412
FILED AS OF DATE: 20230504
DATE AS OF CHANGE: 20230504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Walker Marlan D
CENTRAL INDEX KEY: 0001820187
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 23889471
MAIL ADDRESS:
STREET 1: 951 YAMATO ROAD
STREET 2: SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
BUSINESS PHONE: 561-961-1900
MAIL ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0407
4/A
2023-04-12
2023-04-14
0
0000025743
TherapeuticsMD, Inc.
TXMD
0001820187
Walker Marlan D
951 YAMATO ROAD
SUITE 220
BOCA RATON
FL
33431
0
1
0
0
Chief Executive Officer
0
Common Stock
2023-04-26
4
M
0
1010
0.00
A
14041
D
Common Stock
2023-04-26
4
M
0
1734
0.00
A
12307
D
Common Stock
2023-04-26
4
S
0
692
3.6381
D
11615
D
Restricted Stock Units
0.00
2023-04-26
4
M
0
1010
0.00
D
Common Stock
1010
0
D
Restricted Stock Units
0.00
2023-04-26
4
M
0
1734
0.00
D
Common Stock
1734
3466
D
The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.
The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.
Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.
/s/ Marlan D. Walker
2023-05-04